BOBYR, IVAN
 Distribuzione geografica
Continente #
NA - Nord America 910
EU - Europa 337
AS - Asia 165
AF - Africa 43
SA - Sud America 3
Totale 1.458
Nazione #
US - Stati Uniti d'America 908
CN - Cina 80
IT - Italia 64
IE - Irlanda 61
SE - Svezia 59
SG - Singapore 57
UA - Ucraina 49
CI - Costa d'Avorio 37
FR - Francia 31
DE - Germania 27
GB - Regno Unito 17
IN - India 14
DK - Danimarca 11
FI - Finlandia 11
TR - Turchia 8
MA - Marocco 6
KR - Corea 5
RU - Federazione Russa 3
BR - Brasile 2
CA - Canada 2
AR - Argentina 1
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
JP - Giappone 1
PL - Polonia 1
Totale 1.458
Città #
Chandler 159
Fairfield 81
Des Moines 80
Ashburn 72
Jacksonville 65
Dublin 56
New York 53
Boardman 42
Abidjan 37
Woodbridge 37
Wilmington 36
Singapore 33
Seattle 29
Houston 23
Lawrence 22
Princeton 22
Cambridge 18
San Mateo 17
Guangzhou 15
San Diego 15
Centro 13
Pune 12
London 9
Ann Arbor 8
Turin 8
Beijing 7
Helsinki 6
Los Angeles 6
Norwalk 5
Rome 5
Shanghai 5
Washington 5
Clifton 3
Osimo 3
Redmond 3
Wuhan 3
Ancona 2
Ginosa 2
Jiaxing 2
Kilburn 2
Rimini 2
Santa Clara 2
Toronto 2
Acton 1
Alba 1
Alexandria 1
Ascoli Piceno 1
Bern 1
Brussels 1
Castelfidardo 1
Changsha 1
Chengdu 1
Civitanova Marche 1
Dalian 1
Filottrano 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Gatchina 1
Hounslow 1
Islington 1
Marche 1
Montesilvano 1
Moscow 1
Naples 1
Napoli 1
Qingdao 1
Quanzhou 1
Ramos Mejia 1
Riva 1
Saint Petersburg 1
San Benedetto Del Tronto 1
Shenzhen 1
Shijiazhuang 1
Ternopil 1
Urbino 1
Warsaw 1
Wuxi 1
Yiwu 1
Yong'an 1
Zhengzhou 1
Totale 1.065
Nome #
Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series 113
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 88
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate 84
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 83
Skin Involvement in SARS-CoV-2 Infection: Case Series 79
Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives 76
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 75
Grooved probe nail surgery: A pandemic–induced approach 72
Granuloma faciale successfully treated with ingenol mebutate 67
Botulinum Toxin Off-Label Use in Dermatology: A Review 66
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 65
Relapsing acute generalized exanthematous pustolosis: a guess. 64
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 63
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 58
Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis 56
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 53
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 52
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 51
“SENECA” Sinecatechins 10% ointment: A green tea extract for the treatment of actinic keratosis. Case series 51
Topical application of fumaric acid esters improves appearance of nail psoriasis 48
Asymptomatic pigmentation of the skin in a child: babywipes, once again 44
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 31
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 31
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 20
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 17
Totale 1.507
Categoria #
all - tutte 9.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 0 0 13 3 18 6 2 17
2020/2021298 28 26 32 10 25 6 12 20 27 51 37 24
2021/2022174 5 25 6 0 32 11 2 9 17 7 26 34
2022/2023450 30 55 30 41 23 117 1 26 84 2 28 13
2023/2024250 39 4 19 18 34 89 7 12 0 6 0 22
2024/2025172 84 32 10 7 18 21 0 0 0 0 0 0
Totale 1.507